TNF-α inhibitor-induced alopecia in psoriatic disease patients: a pharmacovigilance study

TNF-α inhibitor-induced alopecia in psoriatic disease patients: a pharmacovigilance study

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.

Бібліографічні деталі
Автор:	Afroza, Halima
Інші автори:	Talukder, Mesbah
Формат:	Дисертація
Мова:	English
Опубліковано:	Brac University 2024
Предмети:	Psoriasis Alopecia TNF-α inhibitor FAERS ROR Disproportionality analysis
Онлайн доступ:	http://hdl.handle.net/10361/22075

Схожі ресурси

A pharmacovigilance study on FDA approved interleukin inhibitor-associated alopecia in the treatment of psoriasis
за авторством: Islam, Nahidul
Опубліковано: (2023)

Isolation and identification of α-amylase producing soil microorganisms and partial characterization of α-Amylase enzyme
за авторством: Tamanna, Shams Tahsin
Опубліковано: (2020)

Safety and efficacy of dutasteride for male Androgenetic Alopecia
за авторством: Islam, S.M. Zahidul
Опубліковано: (2024)

Relationship between SGLT2 inhibitor use and risk of lower limb amputations: a pharmacovigilance study
за авторством: Khandker, Tahia Anjum
Опубліковано: (2024)

Pharmacokinetics, safety, efficacy and immunogenicity of Adalimumab biosimilar ABP-501in rheumatoid arthritis and plaque psoriasis
за авторством: Akter, Anika
Опубліковано: (2022)

SHP2 inhibitors: Recent advancements and potential breakthroughs in cancer therapy
за авторством: Meem, Manila
Опубліковано: (2023)

Inhibition of Fibroblast Activation Protein alpha (FAP-α) in Colorectal Cancer
за авторством: Tabassum, Azwada
Опубліковано: (2021)

Identification of FAP inhibitors using in silico simulation study
за авторством: Deeba, Maliha Tasnim
Опубліковано: (2018)

Biologics and Biosimilars as Treatment Options for Psoriasis
за авторством: Moya, Amena Khatun
Опубліковано: (2023)

Investigation of adverse effects of oral voriconazole in the treatment of fungal infection using The FDA Adverse Event Reporting System (FAERS)
за авторством: Onanna, Kazi
Опубліковано: (2024)

Efficacy and safety of monotherapy and combination therapy of oral minoxidil for androgenetic alopecia: a structured review
за авторством: Jahan, Safrin
Опубліковано: (2023)

A review on potential of PARP inhibitors in the treatment of prostate cancer
за авторством: Islam, Saidul
Опубліковано: (2022)

Association of GLP-1 receptor agonists and risk of pancreatitis: a pharmacovigilance study based on FAERS database
за авторством: Bishakha, Adwiza Chakraborty
Опубліковано: (2024)

A pharmacovigilance study on Memantine: signal detection of Rhabdomyolysis and death
за авторством: Bakar, Osama Bin Abu
Опубліковано: (2024)

Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
за авторством: Flora, Sanzida Alam
Опубліковано: (2024)

A review on newly approved PARP inhibitors: Talazoparib and Olaparib
за авторством: Karim, Azrin
Опубліковано: (2024)

A review on the role of Epigenetics in Psychiatry: Etiology, contemporary medicine and future perspectives
за авторством: Oshin, Sadia Afrin
Опубліковано: (2021)

A review of comparison on efficacy, safety and cost effectiveness of cholinesterase inhibitors, NMDA antagonists and combination therapy in the treatment of Alzheimer’s disease
за авторством: Haque, Mushfiqul
Опубліковано: (2019)

Effect Of sodium glucose co-transporter 2 inhibitors on weight reduction in overweight and obese population: A review
за авторством: Mahin, Md. Tamjidur Rahman
Опубліковано: (2024)

Female Alopecia
за авторством: TrÃ¼eb
Опубліковано: (2013)

A review on Bruton's Tyrosine Kinase inhibitors to outline the scopes of further advancements in the treatment of cancer
за авторством: Khan, Muidul Hasan
Опубліковано: (2024)

Induced pluripotent stem cells: a novel tool for modelling and treating Parkinson’s disease
за авторством: Tanin, Nahid Sultana
Опубліковано: (2022)

A review on cyclin-dependent kinase 7 (CDK7) Inhibitors as anticancer agents
за авторством: Sorno, Rubina Haque
Опубліковано: (2024)

Detection of skin diseases using deep learning
за авторством: Shodoy, Masuk Ur Rahman
Опубліковано: (2024)

Pharmacoepidemiology and Pharmacovigilance

Synthesis and sar o acne medication
за авторством: Naureen, Tasnia
Опубліковано: (2024)

Immunotherapeutic approaches to treat cancer: Prospects and challenges
за авторством: Fred, Namanda Rogers
Опубліковано: (2021)

Importance of biologically active agents over other therapies in Rheumatoid Arthritis- a review
за авторством: Mehreen, Elnaj
Опубліковано: (2021)

HPLC method development for the analysis of linagliptin
за авторством: Mimiya, Ruhani Amrin
Опубліковано: (2020)

RIPK pathway, as a potential target, for cancer treatment - a review
за авторством: Jahan, Nusrat
Опубліковано: (2024)

Importance of biologics in rheumatoid arthritis management
за авторством: Riyadh, S. M.
Опубліковано: (2022)

Pharmacovigilance in the European Union
за авторством: Kaeding
Опубліковано: (2017)

A review of next-generation immuno-oncology agents for cancer therapy: recent dictation shifts in cancer immunotherapy
за авторством: Ratu, Tabassum
Опубліковано: (2024)

Pharmacoepidemiology and pharmacovigilance : synergistic tools to better Investigate drug safety /
за авторством: Nour, Sabrina
Опубліковано: (2019)

Comprehensive review on importance, challenges and future prospects of nanotechnology and combination therapy for Alzheimer’s disease
за авторством: Ishrat, Nowshin
Опубліковано: (2024)

Immunotherapy in the Management of Lung Cancer
за авторством: Tasnim, Humayra
Опубліковано: (2022)

Recent advances in Cancer treatment targeting autophagy and future aspects
за авторством: Emon, Kamrul Hasan
Опубліковано: (2022)

Oral terbinafine-, fluconazole-, ravuconazole-, oteseconazole-induced hepatotoxicity and acute kidney injury in the treatment of onychomycosis: a pharmacovigilance study
за авторством: Rahman, Towsifur
Опубліковано: (2024)

Tamoxifen: The ideal post operative hormonal therapy to demote Ductal Carcinoma in Situ
за авторством: Mirza, Maisa Tasnim
Опубліковано: (2023)

Antihypertensive drugs and risk of cancer: A pharmacovigilance study
за авторством: Rahman, Ahadina
Опубліковано: (2018)